Yesenia Covarrubias1, Kathryn J Fowler1, Adrija Mamidipalli1, Gavin Hamilton1, Tanya Wolfson2, Olof Dahlqvist Leinhard3,4,5, Garth Jacobsen6, Santiago Horgan6, Jeffrey B Schwimmer7,8, Scott B Reeder9,10,11,12, Claude B Sirlin1. 1. Liver Imaging Group, Department of Radiology, University of California, San Diego School of Medicine, La Jolla, California, USA. 2. Computational and Applied Statistics Laboratory, San Diego Supercomputer Center, University of California, San Diego, La Jolla, California, USA. 3. AMRA Medical AB, Linköping, Sweden. 4. Center for Medical Image Science and Visualization, Linköping, Sweden. 5. Department of Medicine and Health, Linköping, University, Linköping, Sweden. 6. Department of Surgery, University of California, San Diego, La Jolla, California, USA. 7. Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, University of California, San Diego, La Jolla, California, USA. 8. Department of Gastroenterology, Rady Children's Hospital San Diego, San Diego, California, USA. 9. Department of Radiology, University of Wisconsin - Madison, Madison, Wisconsin, USA. 10. Department of Medical Physics, University of Wisconsin - Madison, Madison, Wisconsin, USA. 11. Department of Biomedical Engineering, University of Wisconsin - Madison, Madison, Wisconsin, USA. 12. Department of Medicine, University of Wisconsin - Madison, Madison, Wisconsin, USA.
Abstract
BACKGROUND: Quantitative-chemical-shift-encoded (CSE)-MRI methods have been applied to the liver. The feasibility and potential utility CSE-MRI in monitoring changes in pancreatic proton density fat fraction (PDFF) have not yet been demonstrated. PURPOSE: To use quantitative CSE-MRI to estimate pancreatic fat changes during a weight-loss program in adults with severe obesity and nonalcoholic fatty liver disease (NAFLD). To explore the relationship of reduction in pancreatic PDFF with reductions in anthropometric indices. STUDY TYPE: Prospective/longitudinal. POPULATION: Nine adults with severe obesity and NAFLD enrolled in a weight-loss program. FIELD STRENGTH/SEQUENCE: CSE-MRI fat quantification techniques and multistation-volumetric fat/water separation techniques were performed at 3 T. ASSESSMENT: PDFF values were recorded from parametric maps colocalized across timepoints. STATISTICAL TESTS: Rates of change of log-transformed variables across time were determined (linear-regression), and their significance assessed compared with no change (Wilcoxon test). Rates of change were correlated pairwise (Spearman's correlation). RESULTS: Mean pancreatic PDFF decreased by 5.7% (range 0.7-17.7%) from 14.3 to 8.6%, hepatic PDFF by 11.4% (2.6-22.0%) from 14.8 to 3.4%, weight by 30.9 kg (17.3-64.2 kg) from 119.0 to 88.1 kg, body mass index by 11.0 kg/m2 (6.3-19.1 kg/m2 ) from 44.1 to 32.9 kg/m2 , waist circumference (WC) by 25.2 cm (4.0-41.0 cm) from 133.1 to 107.9 cm, HC by 23.5 cm (4.5-47.0 cm) from 135.8 to 112.3 cm, visceral adipose tissue (VAT) by 2.9 L (1.7-5.7 L) from 7.1 to 4.2 L, subcutaneous adipose tissue (SCAT) by 4.0 L (2.9-7.4 L) from 15.0 to 11.0 L. Log-transformed rate of change for pancreatic PDFF was moderately correlated with log-transformed rates for hepatic PDFF, VAT, SCAT, and WC (ρ = 0.5, 0.47, 0.45, and 0.48, respectively), although not statistically significant. DATA CONCLUSION: Changes in pancreatic PDFF can be estimated by quantitative CSE-MRI in adults undergoing a weight-loss surgery program. Pancreatic and hepatic PDFF and anthropometric indices decreased significantly. LEVEL OF EVIDENCE: 2 Technical Efficacy Stage: 1 J. Magn. Reson. Imaging 2019;50:1092-1102.
BACKGROUND: Quantitative-chemical-shift-encoded (CSE)-MRI methods have been applied to the liver. The feasibility and potential utility CSE-MRI in monitoring changes in pancreatic proton density fat fraction (PDFF) have not yet been demonstrated. PURPOSE: To use quantitative CSE-MRI to estimate pancreaticfat changes during a weight-loss program in adults with severe obesity and nonalcoholic fatty liver disease (NAFLD). To explore the relationship of reduction in pancreatic PDFF with reductions in anthropometric indices. STUDY TYPE: Prospective/longitudinal. POPULATION: Nine adults with severe obesity and NAFLD enrolled in a weight-loss program. FIELD STRENGTH/SEQUENCE: CSE-MRI fat quantification techniques and multistation-volumetric fat/water separation techniques were performed at 3 T. ASSESSMENT: PDFF values were recorded from parametric maps colocalized across timepoints. STATISTICAL TESTS: Rates of change of log-transformed variables across time were determined (linear-regression), and their significance assessed compared with no change (Wilcoxon test). Rates of change were correlated pairwise (Spearman's correlation). RESULTS: Mean pancreatic PDFF decreased by 5.7% (range 0.7-17.7%) from 14.3 to 8.6%, hepatic PDFF by 11.4% (2.6-22.0%) from 14.8 to 3.4%, weight by 30.9 kg (17.3-64.2 kg) from 119.0 to 88.1 kg, body mass index by 11.0 kg/m2 (6.3-19.1 kg/m2 ) from 44.1 to 32.9 kg/m2 , waist circumference (WC) by 25.2 cm (4.0-41.0 cm) from 133.1 to 107.9 cm, HC by 23.5 cm (4.5-47.0 cm) from 135.8 to 112.3 cm, visceral adipose tissue (VAT) by 2.9 L (1.7-5.7 L) from 7.1 to 4.2 L, subcutaneous adipose tissue (SCAT) by 4.0 L (2.9-7.4 L) from 15.0 to 11.0 L. Log-transformed rate of change for pancreatic PDFF was moderately correlated with log-transformed rates for hepatic PDFF, VAT, SCAT, and WC (ρ = 0.5, 0.47, 0.45, and 0.48, respectively), although not statistically significant. DATA CONCLUSION: Changes in pancreatic PDFF can be estimated by quantitative CSE-MRI in adults undergoing a weight-loss surgery program. Pancreatic and hepatic PDFF and anthropometric indices decreased significantly. LEVEL OF EVIDENCE: 2 Technical Efficacy Stage: 1 J. Magn. Reson. Imaging 2019;50:1092-1102.
Authors: Takeshi Yokoo; Masoud Shiehmorteza; Gavin Hamilton; Tanya Wolfson; Michael E Schroeder; Michael S Middleton; Mark Bydder; Anthony C Gamst; Yuko Kono; Alexander Kuo; Heather M Patton; Santiago Horgan; Joel E Lavine; Jeffrey B Schwimmer; Claude B Sirlin Journal: Radiology Date: 2011-01-06 Impact factor: 11.105
Authors: L Lionetti; M P Mollica; A Lombardi; G Cavaliere; G Gifuni; A Barletta Journal: Nutr Metab Cardiovasc Dis Date: 2009-01-25 Impact factor: 4.222
Authors: Huanzhou Yu; Ann Shimakawa; Charles A McKenzie; Ethan Brodsky; Jean H Brittain; Scott B Reeder Journal: Magn Reson Med Date: 2008-11 Impact factor: 4.668
Authors: Katherine E Pinnick; Stephan C Collins; Constantine Londos; Dominique Gauguier; Anne Clark; Barbara A Fielding Journal: Obesity (Silver Spring) Date: 2008-01-17 Impact factor: 5.002
Authors: Maarten E Tushuizen; Mathijs C Bunck; Petra J Pouwels; Saskia Bontemps; Jan Hein T van Waesberghe; Roger K Schindhelm; Andrea Mari; Robert J Heine; Michaela Diamant Journal: Diabetes Care Date: 2007-07-31 Impact factor: 19.112
Authors: M L Phillips; S Boase; S Wahlroos; M Dugar; L Kow; J Stahl; J P Slavotinek; R Valentine; J Toouli; C H Thompson Journal: Diabetes Obes Metab Date: 2007-10-17 Impact factor: 6.577